Pharmaceutics (Sep 2023)

(-)-5-Demethoxygrandisin B a New Lignan from <i>Virola surinamensis (Rol.) Warb.</i> Leaves: Evaluation of the Leishmanicidal Activity by In Vitro and In Silico Approaches

  • Steven Souza Paes,
  • João Victor Silva-Silva,
  • Paulo Wender Portal Gomes,
  • Luely Oliveira da Silva,
  • Ana Paula Lima da Costa,
  • Manoel Leão Lopes Júnior,
  • Daiana de Jesus Hardoim,
  • Carla J. Moragas-Tellis,
  • Noemi Nosomi Taniwaki,
  • Alvaro Luiz Bertho,
  • Fábio Alberto de Molfetta,
  • Fernando Almeida-Souza,
  • Lourivaldo Silva Santos,
  • Kátia da Silva Calabrese

DOI
https://doi.org/10.3390/pharmaceutics15092292
Journal volume & issue
Vol. 15, no. 9
p. 2292

Abstract

Read online

Leishmaniasis is a complex disease caused by infection with different Leishmania parasites. The number of medications used for its treatment is still limited and the discovery of new drugs is a valuable approach. In this context, here we describe the in vitro leishmanicidal activity and the in silico interaction between trypanothione reductase (TryR) and (-)-5-demethoxygrandisin B from the leaves of Virola surinamensis (Rol.) Warb. The compound (-)-5-demethoxygrandisin B was isolated from V. surinamensis leaves, a plant found in the Brazilian Amazon, and it was characterized as (7R,8S,7′R,8′S)-3,4,5,3′,4′-pentamethoxy-7,7′-epoxylignan. In vitro antileishmanial activity was examined against Leishmania amazonensis, covering both promastigote and intracellular amastigote phases. Cytotoxicity and nitrite production were gauged using BALB/c peritoneal macrophages. Moreover, transmission electron microscopy was applied to probe ultrastructural alterations, and flow cytometry assessed the shifts in the mitochondrial membrane potential. In silico methods such as molecular docking and molecular dynamics assessed the interaction between the most stable configuration of (-)-5-demethoxygrandisin B and TryR from L. infantum (PDB ID 2JK6). As a result, the (-)-5-demethoxygrandisin B was active against promastigote (IC50 7.0 µM) and intracellular amastigote (IC50 26.04 µM) forms of L. amazonensis, with acceptable selectivity indexes. (-)-5-demethoxygrandisin B caused ultrastructural changes in promastigotes, including mitochondrial swelling, altered kDNA patterns, vacuoles, vesicular structures, autophagosomes, and enlarged flagellar pockets. It reduced the mitochondria membrane potential and formed bonds with important residues in the TryR enzyme. The molecular dynamics simulations showed stability and favorable interaction with TryR. The compound targets L. amazonensis mitochondria via TryR enzyme inhibition.

Keywords